Gadolinium neutron capture in glioblastoma multiforme cells

International Journal of Radiation Biology

Volumn 84, Issue 12, 2008, Pages 1130-1139

  Yasui, Linda S ^a   Andorf, Christine ^b   Schneider, Linda ^b   Kroc, Thomas ^b   Lennox, Arlene ^b   Saroja, K R ^b  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b FERMI NATIONAL ACCELERATOR LABORATORY   (United States)

Author keywords

Auger emitters; Gd neutron capture; Glioblastoma cells

Indexed keywords

GADOLINIUM PENTETATE;

CANCER CELL; CELL KILLING; CELL SURVIVAL; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG MECHANISM; FAST NEUTRON THERAPY; GAMMA RADIATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; GADOLINIUM; GADOLINIUM DTPA; GAMMA RAYS; GLIOBLASTOMA; HUMANS; NEUTRONS;

EID: 57349085196     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802538092     Document Type: Conference Paper

References (43)

1. Alpen EL. 1998. In: Radiation biophysics, San Diego, CA: Academic Press. pp 92-96.
2. Bewley DK, Fowler JL, Morgan RL. 1963. VII. Experiments on the skin of pigs with fast neutrons and 8 MV X rays including some effects of dose fractionation. British Journal of Radiology 36:107-115.
3. Bernard EJ, Mitchell JB, Deen D, Cardell M, Rosenthal DI, Brown JM. 2000. Re-evaluating gadolinium (III) texaphryn as a radiosensitizing agent. Cancer Research 60:86-91.
4. Britten RA, Peters LA, Murray D. 2001. Biological factors influencing the RBE of neutrons: Implications for their past, present and future use in radiotherapy. Radiation Research 156:125-135.
5. (p-> Be+) neutrons of human cells differing in photon sensitivity. International Journal of Radiation Biology 61:805-812.
6. Catterall M, Bewley D. 1979. In: Fast neutrons in the treatment of cancer, London: Academic Press. p 394.
7. Catterall M, Bloom HJG, Ash DV, Walsh L, Richardson A, Uttley D, Gowing N, Lewis P, Bhaucer B. 1980. Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot study. International Journal of Radiation, Oncology, Biology and Physics 6:261-266.
8. Chapman D. 1980. Biophysical models of mammalian cell inactivation by radiation. In: Meyn RE, Withers HR, editors. Radiation biology in cancer research, New York: Raven Press. pp 21-32.
9. Cole A. 1969. Absorption of 20-eV to 50,000-eV electron beams in air and plastic. Radiation Research 38:7-33.
10. DeStasio G, Casalbore P, Pallini R, Gilbert B, Sanita F, Ciotti MT, Rosi G, Festinesi A, Larocca LM, Rinelli A, Perret D, Mogk DW, Perfetti P, Mehta MP, Mercanti D. 2001. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Research 61:4272-4277.
11. DeStasio G, Rajesh D, Casalbore P, Daniels MJ, Erhardt RJ, Frazer BH, Wiese LM, Richter KL, Sonderegger BR, Bilgert B, Schaub S, Cannara RJ, Crawford JF, Gilles MK, Tyliszczak T, Folwer JF, Larocca LM, Howard SP, Mercanti D, Mehta MP. Pallini R. 2005. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy? Neurological Research 27:387-398.
12. Elkind MM. 1984. Repair processes in radiation biology. Radiation Research 100:425-449.
13. Elkind MM, Whitmore GF. 1967. In: The radiobiology of cultured mammalian cells, New York: Gordon and Breach. p 60.
14. Field SB. 1976. An historical survey of radiobiology and radiotherapy with fast neutrons. Current Topics in Radiation Research Quarterly 11:1-86.
15. Franken NAP, Bergs JWJ, Kok TT, Kuperus RRN, Stecher-Rasmussen F, Haveban J, Van Bree C, Stalpers LJA. 2006. Gadolinium enhances the sensitivity of SW-1573 cells for thermal neutron irradiation. Oncology Reports 15:715-720.
16. Goorley T, Nikjoo H, 2000. electron and photon spectra for three gadolinium-based cancer therapy approaches. Radiation Research 154:556-563.
17. Gragg RL, Humphrey RM, Meyn RE. 1977. The response of Chinese Hamster Ovary cells to fast neutron radiotherapy beams. II. Sublethal and potentially lethal damage recovery capabilities. Radiation Research 71:461-470.
18. Gragg RL, Humphrey RM, Thames HD, Meyn RE. 1978. The response of Chinese Hamster Ovary cells to fast neutron radiotherapy beams. III. Variation in relative biological effectiveness with position in cell cycle. Radiation Research 76: 283-291.
19. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. 1953. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 26:638-648.
20. Gueulette J, Beauduin M, Gregoire V, Vynckier S, DeCoster BM, Octave-Prignot M, Wambersie A, Strijkmans K, DeSchrijver A, El-Akkad S, Bohm L, Slabbert JP, Jones DT, Maughan R, Onoda J, Yudelev M, Porter AT, Powers WE, Sabattier R, Breteau N, Courdi A, Brassart N, Chauvel P. 1996. RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutron therapy facilities. Bulletin of Cancer Radiotherapy 83:55s-63.
21. Gupta N, Hu LJ, Deen DF. 1997. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. International Journal of Radiation Oncology, Biology and Physics 37:885-895.
22. Hall EJ. 1998. In: Radiobiology for the radiologist. 3rd ed. Philadelphia, PA: J.B. Lippincott Co. pp 12-15.
23. ICRU Report 26. 1977. In: Neutron dosimetry for biology and medicine, Washington, DC: International Commission on Radiation Units and Measurements.
24. Kataoka Y, Murley JS, Patel R, Grdina DJ. 2000. Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines. International Journal of Radiation Biology 76:633-639.
25. Ke LD, Shi Y-X, Im S-A, Chen X, Ung WK. 2000. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast factor production to antiogeneisis and tumorigenesis in human glioma cell lines. Clinical Cancer Research 6:2567-2572.
26. Lang FF, Yung WKA, Raju U, Libunao F, Terry NHA, Tofilon PJ. 1998. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. Journal of Neurosurgery 89:125-132.
27. Martin RF, D'Cunha G, Pardee M, Allen BJ. 1988. Induction of double strand breaks following neutron capture by DNA bound 157Gd. International Journal of Radiation Biology 54: 205-208.
28. Millar BC, Fielden EM,Millar JL. 1978. Interpretation of survival-curve data for Chinese hamster cells, line V-79 using the multi-target, multi-target with initial slope, and α, β equations. International Journal of Radiation Biology 33:599-603.
29. Newton DE. 1999. Chemical elements. In: Baker LW, editor. Nuclear data for neutron therapy: Status and future needs, Technical Report IAEA-TECDOC-992. International Atomic Energy Agency, Vienna, Austria, December, 1997. Detroit: Gale.
30. Peak MJ, Wang L, Hill CK, Peak JG. 1991. Comparison of repair of DNA double strand breaks caused by neutron or gamma radiation in cultured human cells. International Journal of Radiation Biology 60:891-898.
31. Ponten J, Westermark B. 1978. Properties of human malignant glioma cells in vitro. Medical Biology 56:184-193.
32. Saroja KR, Mansell J, Hendrickson FR, Cohen L, Lennox A. 1989. Failure of accelerated neutron therapy to control high grade astrocytomas. International Journal of Radiation Oncology, Biology and Physics 27:1295-1297.
33. Stone RS. 1948. Neutron therapy and specific ionization. American Journal of Roentgenology 36:107-115.
34. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belander K, Brandes AA, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for Glioblastoma. New England Journal of Medicine 352: 987-996.
35. Sweezy J, Hertel N, Lennox A. 2005. Filter, collimator and moderating material to achieve boron neutron capture enhanced fast neutron therapy. Radiation Protection Dosimetry 116:470-474.
36. Van Meir EG, Kikuchi T, Taka M, Li H, Diserens A-C, Wojcik BE, Huang H-J, Friedmann T, de Tribolet N, Cavenee WK. 1994. Analysis of the p53 gene and its expression in human Glioblastoma cells. Cancer Research 54:649-652.
37. 125I]iodoHoechst 33342: Contribution of scavengeable effects. International Journal of Radiation Biology 75:1579-1587.
38. Wang Z. 2006. Design of a boron neutron capture enhanced fast neutron therapy assembly. PhD Dissertation. G.W. Woodruff School of Mechanical Engineering. Georgia Institute of Technology.
39. 10B to enhance the tumor dose in fast neutron therapy. Physics Medicine Biology 23:592-602.
40. 125IdU decay. International Journal of Radiation Biology 80:895-903.
41. 125I decay. International Journal of Radiation Biology 49:601-610.
42. 125IUdR cytotoxicity. Radiation Research 102: 106-118.
43. 125I-estrogen decays in estrogen receptor expressing human breast cancer cells. Radiation Research 155:328-334.